Publisher
Springer Science and Business Media LLC
Subject
Surgery,Pediatrics, Perinatology, and Child Health
Reference32 articles.
1. Barrett AJ, Sloand EM (2008) Immunosuppressive therapy for myelodysplastic syndromes: refining the indications. Curr Hematol Malig Rep 3:23–28
2. Baumann I, Niemeyer C, Benett J (2008) Childhood myelodysplastic syndrome. In: Swerdlow S, Campo E, Harris N et al (Hrsg) WHO classification of tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon, S 104–107
3. Bodor C, Renneville A, Smith M et al (2012) Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica 97:890–894
4. Frickhofen N, Heimpel H, Kaltwasser JP et al (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 101:1236–1242
5. Fuhrer M, Rampf U, Baumann I et al (2005) Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 106:2102–2104